Canada House Wellness Group Files Financial Results for April 30, 2017 Fiscal Year and provides Bi-Weekly Update on Status of Management Cease Trade OrderNOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 30, 2017 (GLOBE NEWSWIRE) — Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is pleased to report the financial results and accompanying management discussion and analysis for the fiscal year ended April 30, 2017. Copies are available on the Company’s website...Read More
Canada House is Pleased to Announce Its Joint Venture With Nutritional High, an Expert in Cannabis Oil Extracts and EdiblesTORONTO, Oct. 17, 2017 (GLOBE NEWSWIRE) — Canada House Wellness Group Inc.’s (“Canada House“) (CSE:CHV) wholly owned subsidiary Abba Medix Corp. (“Abba”) and Nutritional High International Inc. (“Nutritional High“) (CSE:EAT) (OTCQB:SPLIF) (FRANKFURT:2NU) have entered into a letter of intent (“LOI“) to create a joint venture (“Joint Venture”) to...Read More
Canada House is the parent company of Marijuana for Trauma Inc., Knalysis Technologies and Abba Medix Corp. The Company’s goal is to become a marketplace leader through strategic partnerships, mergers, and acquisitions to create a fully integrated cannabis therapy company. For more information please visit our Corporate Overview.
Notice: Cautionary Statements Regarding Forward‐Looking Information. Certain statements within this website and related documents pertaining to the Company constitute “forward‐looking statements”, within the meaning of applicable securities laws, including without limitation, statements regarding future estimates, business plans and/or objectives, sales programs, forecasts and projections, assumptions, expectations, and/or beliefs of future performance, are “forward‐looking statements”. Such “forward‐looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. Forward‐looking statements include, but are not limited to, statements with respect to the anticipated effects of the Acquisition, regulatory changes, timeliness of government approvals for the granting of permits and licenses, including the final approval to resume trading on the CSE, changes in medical marijuana prices, actual operating performance of facilities, competition and other risks affecting the Company in particular and the medical marijuana industry generally, including those set out in the Listing Statement.
The Company assumes no responsibility to update or revise forward‐looking information to reflect new events or circumstances unless required by law. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.